HSN-based tax classification follows dominant product character, with specific schedule entries prevailing over general notification rates.

HSN-based tariff classification under the Kerala VAT Act turns on the product's specific scheduled description and its dominant commercial use. Mosquito repellents were treated as insect repellents covered by the Third Schedule, so a contrary notification rate could not override that specific coverage. Lizol and Harpic were analysed as cleaning products whose disinfecting effect was incidental, placing them under the cleaning-agent entry. Dettol was treated as an antiseptic and hygiene product, not a medicament used for therapeutic or prophylactic treatment, so the residuary entry applied. The stated ratio is that the primary character of the product governs classification.

---

---

Issues: (i) Whether mosquito repellents and allied products fell under Entry 44(5) of the Third Schedule to the Kerala Value Added Tax Act, 2003 or under Entry 66 of SRO 82/2006; (ii) Whether Lizol and Harpic were classifiable as disinfectants under Entry 44(5) or as cleaning agents under Entry 27(4) of SRO 82/2006; (iii) Whether Dettol was a medicament under Entry 36(8) of the Third Schedule to the Kerala Value Added Tax Act, 2003 or fell under the residuary entry in SRO 82/2006.

Issue (i): Whether mosquito repellents and allied products fell under Entry 44(5) of the Third Schedule to the Kerala Value Added Tax Act, 2003 or under Entry 66 of SRO 82/2006.

Analysis: The classification had to be tested with reference to the HSN-based interpretative rules appended to the Act. The products answered the description of insect repellents covered by HSN Code 3808, and the specific HSN sub-heading for repellents for insects such as flies and mosquitoes supported classification under the Third Schedule. Once a product was specifically covered by the schedule, the State could not override that coverage by a notification fixing a different rate under Section 6(1)(d) of the Act.

Conclusion: The mosquito repellent products were held to fall under Entry 44(5) of the Third Schedule and not under Entry 66 of SRO 82/2006, in favour of the assessee.

Issue (ii): Whether Lizol and Harpic were classifiable as disinfectants under Entry 44(5) or as cleaning agents under Entry 27(4) of SRO 82/2006.

Analysis: The products were examined by their stated use and commercial description. Their dominant function was found to be cleaning, stain removal and deodorising, even though they also had germ-killing properties. The relevant HSN sub-heading for disinfectants was understood as covering essentially disinfectant products and not cleaning agents that incidentally disinfect. On that basis, the claim that they were covered by the disinfectant entry in the Third Schedule was rejected.

Conclusion: Lizol and Harpic were held not to fall under Entry 44(5) and were classified under Entry 27(4) of SRO 82/2006, against the assessee.

Issue (iii): Whether Dettol was a medicament under Entry 36(8) of the Third Schedule to the Kerala Value Added Tax Act, 2003 or fell under the residuary entry in SRO 82/2006.

Analysis: A medicament must be used for therapeutic or prophylactic treatment in the sense of prevention or cure of disease. Dettol was found to be an antiseptic and hygiene product used for multiple cleansing and household purposes, and not a product shown to prevent or cure disease. As it did not answer the description of a medicament and was not shown to fit any other specific schedule entry, the residuary classification was upheld.

Conclusion: Dettol was held not to be a medicament and was placed under the residuary entry in SRO 82/2006, against the assessee.

Final Conclusion: The appeal succeeded only in respect of the mosquito repellent products, while the classifications of Lizol, Harpic and Dettol were upheld under the notification entries applicable to them.

Ratio Decidendi: For tax classification under a schedule based on HSN nomenclature, the specific scheduled description and the product's dominant commercial use prevail over a general notification, and a product can be treated as a medicament or disinfectant only if that is its essential and primary character.

---